New Trade Free Agreement

U.S.-E.U. Trade Deal Has the Potential to Set a New Global Standard

07.24.13 | By Jay Taylor

Today, PhRMA President and CEO John Castellani testified before the House Energy and Commerce subcommittee on Commerce, Manufacturing and Trade about an ambitious new free trade agreement being negotiated between the United States and the European Union.

The Transatlantic Trade and Investment Partnership (TTIP) has the potential to revolutionize the way we think about free trade agreements and set a new global standard. If negotiated properly, the TTIP could help spur a new wave of biopharmaceutical innovation that will benefit patients on both sides of the Atlantic and across the globe. PhRMA looks forward to working with Congress and President Obama’s administration to help ensure the strongest possible agreement for the United States.

For more information, please read John Castellani’s op-ed published today in The Hill.


Hide Comments

More On PhRMA — powered by PhRMApedia


Cost in Context